Your browser doesn't support javascript.
loading
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer.
Rouanne, Mathieu; Betari, Reem; Radulescu, Camélia; Goubar, Aïcha; Signolle, Nicolas; Neuzillet, Yann; Allory, Yves; Marabelle, Aurélien; Adam, Julien; Lebret, Thierry.
Affiliation
  • Rouanne M; INSERM Unit U1015, Laboratoire de Recherche Translationnelle en Immunothérapie, Gustave Roussy, Villejuif, France; Department of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France. Electronic address: mathieu.rouanne@gustaveroussy.fr.
  • Betari R; Department of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
  • Radulescu C; Department of Pathology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
  • Goubar A; Department of Biostatistics, INSERM Unit U981, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Signolle N; Department of Experimental Pathology, INSERM Unit U981, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Neuzillet Y; Department of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
  • Allory Y; Department of Pathology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France; Institut Curie, CNRS, UMR144, Paris, France.
  • Marabelle A; INSERM Unit U1015, Laboratoire de Recherche Translationnelle en Immunothérapie, Gustave Roussy, Villejuif, France; Drug Development Department (DITEP), Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Adam J; Department of Biostatistics, INSERM Unit U981, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France; Department of Pathology, Gustave Roussy, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
  • Lebret T; Department of Urology, Hôpital Foch, Université Versailles-Saint-Quentin-en-Yvelines, Université Paris-Saclay, Suresnes, France.
Eur J Cancer ; 108: 111-119, 2019 02.
Article in En | MEDLINE | ID: mdl-30654296
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Lymphocytes, Tumor-Infiltrating Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2019 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Lymphocytes, Tumor-Infiltrating Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Cancer Year: 2019 Document type: Article Country of publication: Reino Unido